X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4727) 4727
Publication (915) 915
Paper (532) 532
Patent (126) 126
Conference Proceeding (108) 108
Report (67) 67
Data Set (24) 24
Book Review (21) 21
Book Chapter (20) 20
Dissertation (9) 9
Book / eBook (7) 7
Magazine Article (7) 7
Web Resource (3) 3
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (1203) 1203
high energy physics (1031) 1031
physics (1028) 1028
physical sciences (873) 873
fysik (872) 872
natural sciences (852) 852
naturvetenskap (852) 852
physics of elementary particles and fields (767) 767
high energy physics - experiment (738) 738
phenomenology (643) 643
physics, particles & fields (628) 628
subatomic physics (615) 615
subatomär fysik (615) 615
hadron-hadron scattering (543) 543
particle physics (534) 534
physics - high energy physics - experiment (462) 462
nuclear experiment (414) 414
elementary particles, quantum field theory (313) 313
quantum field theories, string theory (291) 291
cern lhc coll (285) 285
experimental results (282) 282
humans (278) 278
物理学 (270) 270
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (249) 249
parton distributions (231) 231
astronomy, astrophysics and cosmology (219) 219
nuclear physics, heavy ions, hadrons (198) 198
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (193) 193
astronomy & astrophysics (187) 187
large hadron collider (185) 185
astrophysics (183) 183
measurement science and instrumentation (175) 175
nuclear energy (175) 175
collisions (174) 174
female (174) 174
index medicus (156) 156
physics, nuclear (143) 143
scattering [p p] (142) 142
p p: scattering (141) 141
hep (139) 139
male (137) 137
colliding beams [p p] (135) 135
high energy astrophysical phenomena (129) 129
quarks (129) 129
p p: colliding beams (128) 128
nuclear and high energy physics (127) 127
physics, multidisciplinary (126) 126
detectors (124) 124
luminosity (123) 123
physics and astronomy (121) 121
science & technology (121) 121
ciências físicas [ciências naturais] (119) 119
particle physics - experiment (119) 119
13000 gev-cms (117) 117
nuclear and particle physics. atomic energy. radioactivity (117) 117
classical and quantum gravitation, relativity theory (115) 115
ex (115) 115
quantum physics (115) 115
decay (108) 108
analysis (105) 105
engineering (101) 101
middle aged (100) 100
regular - experimental physics (100) 100
supersymmetry (99) 99
8000 gev-cms (96) 96
animals (95) 95
pair production (93) 93
transverse momentum (93) 93
chemistry, multidisciplinary (91) 91
higgs physics (90) 90
cross sections (86) 86
leptons (86) 86
chemistry (85) 85
regular article - experimental physics (85) 85
adult (84) 84
particle collisions (83) 83
beyond standard model (79) 79
mice (78) 78
aged (76) 76
bosons (75) 75
searching (75) 75
standard model (74) 74
engineering, chemical (73) 73
settore fis/01 - fisica sperimentale (73) 73
confidence intervals (71) 71
liquid argon calorimeter (71) 71
instrumentation and detectors (69) 69
plus plus (67) 67
background (66) 66
metallurgy (66) 66
lhc (65) 65
settore fis/04 - fisica nucleare e subnucleare (65) 65
hadron colliders (61) 61
hadron (58) 58
measurement (57) 57
qcd (57) 57
top physics (57) 57
jets (56) 56
proton (56) 56
model (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4720) 4720
Romanian (292) 292
French (180) 180
German (23) 23
Spanish (15) 15
Chinese (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Physical Journal C, ISSN 1434-6044, 2017, Volume 77, Issue 7, pp. 1 - 73
Journal Article
by Aaron, FD and Alexa, C and Alimujiang, K and Andreev, V and Antunovic, B and Backovic, S and Baghdasaryan, A and Barrelet, E and Bartel, W and Begzsuren, K and Belousov, A and Bizot, JC and Boudry, V and Bozovic-Jelisavcic, I and Bracinik, J and Brandt, G and Brinkmann, M and Brisson, V and Bruncko, D and Bunyatyan, A and Buschhorn, G and Bystritskaya, L and Campbell, AJ and Avila, KBC and Cerny, K and Cerny, V and Chekelian, V and Cholewa, A and Contreras, JG and Coughlan, JA and Cozzika, G and Cvach, J and Dainton, JB and Daum, K and Deak, M and Delcourt, B and Delvax, J and De Wolf, EA and Diaconu, C and Dodonov, V and Dossanov, A and Dubak, A and Eckerlin, G and Efremenko, V and Egli, S and Eliseev, A and Elsen, E and Falkiewicz, A and Favart, L and Fedotov, A and Felst, R and Feltesse, J and Ferencei, J and Fischer, DJ and Fleischer, M and Fomenko, A and Gabathuler, E and Gayler, J and Ghazaryan, S and Glazov, A and Glushkov, I and Goerlich, L and Gogitidze, N and Gouzevitch, M and Grab, C and Greenshaw, T and Grell, BR and Grindhammer, G and Habib, S and Haidt, D and Helebrant, C and Henderson, RCW and Hennekemper, E and Henschel, H and Herbst, M and Herrer, G and Hildebrandt, M and Hiller, KH and Hoffmann, D and Horisberger, R and Hreus, T and Jacquet, M and Janssen, X and Jonsson, L and Jung, AW and Jung, H and Kapichine, M and Katzy, J and Kenyon, IR and Kiesling, C and Klein, M and Kleinwort, C and Kluge, T and Knutsson, A and Kogler, R and Kostka, P and Kraemer, M and Krastev, K and Kretzschmar, J and Kropivnitskaya, A and ... and Lund University and Partikelfysik and Lunds universitet and Particle Physics
PHYSICS LETTERS B, ISSN 0370-2693, 03/2010, Volume 686, Issue 2-3, pp. 91 - 100
Journal Article
by Aaron, FD and Alexa, C and Andreev, V and Backovic, S and Baghdasaryan, A and Baghdasaryan, S and Barrelet, E and Bartel, W and Begzsuren, K and Belousov, A and Belov, P and Bizot, JC and Boenig, MO and Boudry, V and Bozovic-Jelisavcic, I and Bracinik, J and Brandt, G and Brinkmann, M and Brisson, V and Britzger, D and Bruncko, D and Bunyatyan, A and Buschhorn, G and Bystritskaya, L and Campbell, AJ and Avila, KBC and Ceccopieri, F and Cerny, K and Cerny, V and Chekelian, V and Contreras, JG and Coughlan, JA and Cvach, J and Dainton, JB and Daum, K and Delcourt, B and Delvax, J and De Wolf, EA and Diaconu, C and Dobre, M and Dodonov, V and Dossanov, A and Dubak, A and Eckerlin, G and Egli, S and Eliseev, A and Elsen, E and Favart, L and Fedotov, A and Felst, R and Feltesse, J and Ferencei, J and Fischer, DJ and Fleischer, M and Fomenko, A and Gabathuler, E and Gayler, J and Ghazaryan, S and Glazov, A and Goerlich, L and Gogitidze, N and Gouzevitch, M and Grab, C and Grebenyuk, A and Greenshaw, T and Grell, BR and Grindhammer, G and Habib, S and Haidt, D and Helebrant, C and Henderson, RCW and Hennekemper, E and Henschel, H and Herbst, M and Herrera, G and Hildebrandt, M and Hiller, KH and Hoffmann, D and Horisberger, R and Hreus, T and Huber, F and Jacquet, M and Janssen, X and Jonsson, L and Jung, AW and Jung, H and Kapichine, M and Kenyon, IR and Kiesling, C and Klein, M and Kleinwort, C and Kluge, T and Kogler, R and Kostka, P and Kraemer, M and Kretzschmar, J and Kruger, K and Landon, MPJ and Lange, W and Lastovicka-Medin, G and ... and Lund University and Partikelfysik and Lunds universitet and Particle Physics
EUROPEAN PHYSICAL JOURNAL C, ISSN 1434-6044, 10/2011, Volume 71, Issue 10
Inclusive production of D* mesons in deep-inelastic ep scattering at HERA is studied in the range 5 < Q(2) < 100 GeV2 of the photon virtuality and 0.02 < y <... 
CROSS-SECTIONS | PARTON DISTRIBUTIONS | INCLUSIVE PRODUCTION | H1 VERTEX DETECTOR | HEAVY QUARKS | EP SCATTERING | FRAGMENTATION FUNCTIONS | O(ALPHA-S) CORRECTIONS | D-ASTERISK | QCD COHERENCE | PHYSICS, PARTICLES & FIELDS | Fysik | Subatomär fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Natural Sciences
Journal Article
by Aaboud, M and Aad, G and Abbott, B and Abdinov, O and Abeloos, B and Abidi, S H and AbouZeid, O S and Abraham, N L and Abramowicz, H and Abreu, H and Abreu, R and Abulaiti, Y and Acharya, B S and Adachi, S and Adamczyk, L and Adelman, J and Adersberger, M and Adye, T and Affolder, A A and Afik, Y and Agatonovic-Jovin, T and Agheorghiesei, C and Aguilar-Saavedra, J A and Ahlen, S P and Ahmadov, F and Aielli, G and Akatsuka, S and Akerstedt, H and Åkesson, T P. A and Akilli, E and Akimov, A V and Alberghi, G L and Albert, J and Albicocco, P and Alconada Verzini, M J and Alderweireldt, S C and Aleksa, M and Aleksandrov, I N and Alexa, C and Alexander, G and Alexopoulos, T and Alhroob, M and Ali, B and Aliev, M and Alimonti, G and Alison, J and Alkire, S P and Allbrooke, B M. M and Allen, B W and Allport, P P and Aloisio, A and Alonso, A and Alonso, F and Alpigiani, C and Alshehri, A A and Alstaty, M I and Alvarez Gonzalez, B and Álvarez Piqueras, D and Alviggi, M G and Amadio, B T and Amaral Coutinho, Y and Amelung, C and Amidei, D and Amor Dos Santos, S P and Amoroso, S and Amundsen, G and Anastopoulos, C and Ancu, L S and Andari, N and Andeen, T and Anders, C F and Anders, J K and Anderson, K J and Andreazza, A and Andrei, V and Angelidakis, S and Angelozzi, I and Angerami, A and Anisenkov, A V and Anjos, N and Annovi, A and Antel, C and Antonelli, M and Antonov, A and Antrim, D J and Anulli, F and Aoki, M and Aperio Bella, L and Arabidze, G and Arai, Y and Araque, J P and Araujo Ferraz, V and Arce, A T. H and Ardell, R E and Arduh, F A and Arguin, J-F and Argyropoulos, S and Arik, M and Armbruster, A J and Armitage, L J and ... and ATLAS Collaboration and The ATLAS collaboration and SLAC National Accelerator Lab., Menlo Park, CA (United States) and Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States) and Oak Ridge National Laboratory, Oak Ridge Leadership Computing Facility (OLCF) and Partikel- och astropartikelfysik and Skolan för teknikvetenskap (SCI) and KTH and Fysik
Journal of High Energy Physics, ISSN 1126-6708, 1/2018, Volume 2018, Issue 1, pp. 1 - 53
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher... 
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article